NDC11 69489041101
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 69489-0411-01 | 69489-0411 |
| 69489-0411-1 | 69489-0411 |
| 69489-411-01 | 69489-411 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Qbrexza | GLYCOPYRRONIUM | Journey Medical Corporation | 5b372650-e56e-47a5-93e2-c0c292017059 | 2026-05-21 | Warnings, Adverse reactions | 69489-411-01 69489-411 69489041101 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.